Milton S. Hershey Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Milton S. Hershey Medical Center sits in the top decile of US sponsors by registered trial count (#93 of 15,742 sponsors by registered trial count).

396 total trials 55 currently recruiting 255 completed early-phase tilt top decile by trial count

Milton S. Hershey Medical Center: 396 sponsored US clinical trials, 55 recruiting.

Milton S. Hershey Medical Center sponsors 396 registered US clinical trials on ClinicalTrials.gov, 55 of them currently recruiting, and 255 completed. 46 of these trials are in Phase 3-4 (later-stage) and 73 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Child Abuse, with 4 trials.

Top-decile sponsor footprint

Milton S. Hershey Medical Center ranks in the top decile of sponsors by registered trial count (#93 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 39/100

255 of 320 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

396 total, page 5 of 8

COMPLETED NA

Doctor-Parent Interactions With Medical Scribes

NCT03473353

COMPLETED

Validating TEE Measurements of Right Ventricular Function

NCT03264183

COMPLETED

Reliability of Topography Measurements in Keratoconus

NCT03511495

TERMINATED Early Phase 1

Angiotensin-(1-7) in Peripheral Arterial Disease

NCT03240068

COMPLETED NA

Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

NCT03280836

COMPLETED NA

The CDR Implementation Trial

NCT03162354

COMPLETED

Ancillary Microbiome Collection From Mother/Infant Pairs During First Year of Life

NCT03236194

COMPLETED NA

Switching to Low Oxidant Content Cigarettes in Adult Smokers

NCT03102931

COMPLETED NA

Infra Red Vein Visualization: Efficacy vs. Standard Technique

NCT03181542

TERMINATED Phase 1

Ketamine and Magnesium in Post-operative Pain Control in Patients Treated With Opioids

NCT02940509

COMPLETED NA

Topical Corticosteroid App

NCT02921503

COMPLETED

The Natural History of Injury-Related Disuse Osteopenia

NCT03868085

TERMINATED

Renal Biomarkers to Predict Recovery Following Venoarterial Extracorporeal Membrane Oxygenation

NCT02978378

COMPLETED NA

Exercise in All ChemoTherapy

NCT03461471

TERMINATED Phase 4

Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH

NCT02549716

COMPLETED NA

Autism Spectrum Ambassador Program

NCT02842671

COMPLETED NA

Working to Increase Stability Through Exercise

NCT02714257

COMPLETED

Objective Pain Score for Chronic Pain Clinic Patients

NCT02882971

COMPLETED NA

Remediation of the Non-Paretic Arm in Stroke

NCT03062930

COMPLETED NA

Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs

NCT02624050

COMPLETED NA

PlayFit Pilot: Encouraging Social Physical Play in the Community

NCT02944370

COMPLETED

Penn State ProduceRx Feasibility Study

NCT02794818

COMPLETED NA

Person-Centered Assessment and Monitoring Systems

NCT03019978

TERMINATED

AKI in Thoracic and Abdominal Surgery

NCT02553174

COMPLETED NA

Optimal Performance of RFA of the Nerves Supplying the Posterior Sacroiliac Joint Complex.

NCT02808962

TERMINATED Phase 4

The Efficacy of Local Anesthetics to Reduce Shoulder Pain Post-Steroid Injections

NCT02592629

COMPLETED NA

Computed Tomography Arteriograms (CTA) Volume Dose Reduction Study

NCT02669784

COMPLETED Phase 2

Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting

NCT02457195

TERMINATED Phase 4

Evaluation of Modafinil vs Placebo for Treatment of Anesthesia Delayed Emergence in Obstructive Sleep Apnea

NCT02494102

COMPLETED NA

Switching to Reduced Oxidant or Nicotine Content Cigarettes in Smokers

NCT02415270

COMPLETED NA

Effectiveness of the Care Coordination, Assessment, and Responsive Engagement Program for Transition-aged Adolescents (t-CARE) With ASD

NCT03019952

TERMINATED Phase 4

Effects of Evening Dose of Immediate Release Methylphenidate on Sleep in Children With ADHD

NCT02638168

COMPLETED NA

Tx for Child Sexual Behavior Problems

NCT02625571

COMPLETED NA

Resilience and Exercise in Advanced Cancer Treatment

NCT02680990

TERMINATED

Post-surgical Pain Assessment in Children: Roles of Skin Conductance and Genomics

NCT02534168

COMPLETED

Improving Autism Screening With Brain-Related miRNA

NCT02712853

COMPLETED NA

Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery

NCT02334059

COMPLETED NA

Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status

NCT01928719

COMPLETED NA

Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders

NCT01928758

COMPLETED NA

Pharmacokinetics of Nicotine Film in Smokers

NCT02239770

COMPLETED

Mobile Monitoring of Fracture Healing

NCT02534259

COMPLETED NA

Development of a Community Engagement Activity for Advance Care Planning

NCT02575417

COMPLETED NA

Complications Associated With Central Venous Access in the NSICU: PICC vs CVC

NCT02314520

COMPLETED NA

Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD

NCT02382848

COMPLETED Phase 4

Administration of Pre-Operative Gabapentin to Patients Undergoing Laparoscopy

NCT02359110

COMPLETED NA

Peer-mentoring, Quality of Life and Caregiver Burden in Patients With Chronic Kidney Disease and Their Caregivers

NCT02429115

COMPLETED Phase 2

Alendronate to Prevent Loss of Bronchoprotection in Asthma

NCT02230332

COMPLETED NA

Penn State TXT2Quit Study

NCT02367391

COMPLETED NA

Oral Liposomal Glutathione Supplementation in Healthy Subjects

NCT02278822

COMPLETED NA

The Value of Integrating Visual Arts: Evaluating the Benefits of Hospital Room Artwork on Inpatient Wellbeing

NCT02357160

← Previous Page 5 of 8 Next →

Phase Distribution

PhaseTrial count
Phase 1 40
Phase 2 33
Phase 3 25
Phase 4 21

What is open in the Milton S. Hershey Medical Center pipeline

55 recruiting of 396 indexed (14% open); 255 completed (64%).

Phase mix: 46 late (III/IV) vs 73 early (I/II) (early-phase heavy).

Top condition: Child Abuse (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Milton S. Hershey Medical Center: open-pipeline peers nationwide

Peers matched on 396 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 10%12%14%16%18%20% Total trials Recruiting share Milton S. Hershey Medical CenterAbramson Cancer Center at Penn MedicineCase Comprehensive Cancer CenterUniversity of NebraskaTakedaUniversity of CincinnatiJohns Hopkins Bloomberg School of Public HealthBeiGeneSeattle Institute for Biomedical and Clinical Research
Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Milton S. Hershey Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 396 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Milton S. Hershey Medical Center page

396 registered trials is a research-attention snapshot, not an endorsement of Milton S. Hershey Medical Center or any single study.

  • 55 of Milton S. Hershey Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Child Abuse is the condition Milton S. Hershey Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Child Abuse trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Milton S. Hershey Medical Center pipeline card: 396 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.